Search results for "Atrial fibrillation"
Digoxin associated with higher mortality in afib patients
Digoxin was associated with a significant increase in all-cause mortality in patients with atrial fibrillation, regardless of gender and whether they had had heart failure, a study found.
https://immattersacp.org/weekly/archives/2012/12/04/4.htm
4 Dec 2012
Warfarin associated with lower stroke, systemic thromboembolism risk in patients with both afib and CKD
The addition of chronic kidney disease (CKD) to atrial fibrillation is associated with an increased risk of stroke or systemic thromboembolism and bleeding. Warfarin treatment was associated with decreasing this risk, a new study found.
https://immattersacp.org/weekly/archives/2012/08/21/6.htm
21 Aug 2012
Warning on steroids; approval for soft-tissue sarcoma drug
This column reviews a warning on testosterone and other anabolic androgenic steroids and approval of a new drug to treat certain adults with soft-tissue sarcoma.
https://immattersacp.org/archives/2017/01/fda-update.htm
1 Jan 2017
The August issue of ACP Hospitalist is online
The August issue of ACP Hospitalist is online and includes stories on patient-centered care, atrial fibrillation, and more.
https://immattersacp.org/weekly/archives/2012/08/21/11.htm
21 Aug 2012
Higher CHADS2 scores can indicate higher risk in patients on anticoagulants
Higher CHADS2 scores pointed to higher risk for adverse outcomes, including stroke, bleeding and death, in patients with atrial fibrillation receiving anticoagulation, according to a new study.
https://immattersacp.org/weekly/archives/2011/11/15/5.htm
15 Nov 2011
Updated guidelines released on antithrombotic therapy, thrombosis prevention
The American College of Chest Physicians released updated guidelines last week on antithrombotic therapy and prevention of thrombosis.
https://immattersacp.org/weekly/archives/2012/02/14/2.htm
14 Feb 2012
Warfarin given to elderly patients within a year of traumatic brain injury associated with net benefit
Resuming warfarin in the year after a traumatic brain injury was associated with a net benefit, due to a reduction in ischemic stroke risk, for elderly patients in a recent study.
https://immattersacp.org/weekly/archives/2014/06/17/5.htm
17 Jun 2014
Rivaroxaban has similar safety, efficacy versus warfarin in older and younger nonvalvular afib patients
Rivaroxaban appears to have similar safety and efficacy compared with warfarin in both older and younger patients with nonvalvular atrial fibrillation, although stroke and major bleeding rates were higher in the former group, a new study found.
https://immattersacp.org/weekly/archives/2014/06/10/6.htm
10 Jun 2014
Task Force finds insufficient evidence on screening for afib
The U.S. Preventive Services Task Force reviewed trials published since 2017 but did not deem them strong enough to show evidence of benefit or harm.
https://immattersacp.org/weekly/archives/2022/02/01/3.htm
1 Feb 2022
Guidance released on use of new oral anticoagulants in nonvalvular afib
The European Heart Rhythm Association published guidance last week on using new oral anticoagulants in patients with nonvalvular atrial fibrillation.
https://immattersacp.org/weekly/archives/2013/05/07/6.htm
7 May 2013